Advanced Enzyme Technologies Limited (NSE:ADVENZYMES)
India flag India · Delayed Price · Currency is INR
281.20
+0.35 (0.12%)
Nov 17, 2026, 9:20 AM IST

NSE:ADVENZYMES Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
1,8541,088942.251,138964.22,674
Short-Term Investments
4,873122.85177.98295.2263.3716.33
Trading Asset Securities
-5,8384,8034,0293,5961,019
Cash & Short-Term Investments
6,7277,0495,9235,4614,8233,709
Cash Growth
11.06%19.01%8.45%13.23%30.03%16.38%
Accounts Receivable
1,3801,4501,154985.681,003884.91
Other Receivables
-7.397.0915.920.0663.54
Receivables
1,3831,4601,1621,0031,025949.31
Inventory
2,0271,7731,5731,4851,2401,209
Prepaid Expenses
-38.4236.2439.6323.2320.97
Other Current Assets
289.18115.83104.48109.44110.27155.55
Total Current Assets
10,42710,4368,7998,0977,2216,044
Property, Plant & Equipment
3,9093,2703,1463,0732,8882,718
Long-Term Investments
9.4750.7156.251.711.70.7
Goodwill
3,7393,6953,3343,2533,2092,961
Other Intangible Assets
427.96469.22523.08582.86608.78663.06
Long-Term Deferred Tax Assets
69.1248.78101.92142.82113.4274.2
Other Long-Term Assets
474.6417.59252.16203.84176.73215.04
Total Assets
19,05718,38816,21315,35514,21812,676

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
448.48399.59194.82157.59242.21178.97
Accrued Expenses
-197.27161.73141.97124.55124.62
Short-Term Debt
-111.83111.45175.849.8919.2
Current Portion of Long-Term Debt
130.1812.5910.543.581.965.99
Current Portion of Leases
45.2679.1162.3465.5459.3757.28
Current Income Taxes Payable
63.0110.1445.9291.4114.841.99
Other Current Liabilities
483.79256.69375.67427.68282.84216.17
Total Current Liabilities
1,1711,067962.471,064775.66604.22
Long-Term Debt
87.3277.190.2966.5272.7773.53
Long-Term Leases
274.2339.46118.88161.64151191.3
Pension & Post-Retirement Benefits
-51.3117.237.154.137.58
Long-Term Deferred Tax Liabilities
311.5318.73336.34343.24372.27392.5
Other Long-Term Liabilities
14.612.571.561.710.933.1
Total Liabilities
1,8581,5561,5271,6441,3771,272

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
220.53223.85223.76223.65223.65223.6
Additional Paid-In Capital
-856.18840.22821.31821.31813.55
Retained Earnings
-12,68411,57010,83410,0629,022
Comprehensive Income & Other
16,4272,5551,5751,3631,244826.43
Total Common Equity
16,64816,32014,20913,24112,35110,886
Minority Interest
551.04511.65478.07469.52491.02517.93
Shareholders' Equity
17,19916,83114,68713,71112,84211,404
Total Liabilities & Equity
19,05718,38816,21315,35514,21812,676

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
536.99320.09393.5473.08334.99347.3
Net Cash (Debt)
6,1906,7295,5294,9884,4883,362
Net Cash Growth
8.40%21.69%10.85%11.14%33.49%15.63%
Net Cash Per Share
55.2460.0649.3744.5840.1430.05
Filing Date Shares Outstanding
111.15111.93111.88111.82111.82111.8
Total Common Shares Outstanding
111.15111.93111.88111.82111.82111.8
Working Capital
9,2569,3697,8367,0346,4455,440
Book Value Per Share
149.78145.81127.00118.41110.4597.37
Tangible Book Value
12,48112,15610,3519,4058,5337,262
Tangible Book Value Per Share
112.28108.6092.5284.1176.3164.96
Land
-574.43574.43568.36559.12517.39
Buildings
-844.67843.09730.58723.47627.92
Machinery
-3,0672,9582,6662,5002,342
Construction In Progress
-511.69216.91307.37156.0996.28
Leasehold Improvements
-128.01127.05126.51115.34103.32